智慧吸入器市場:各產品,各流通管道,各地區-規模,佔有率,展望,機會分析,2023~2030年
市場調查報告書
商品編碼
1290618

智慧吸入器市場:各產品,各流通管道,各地區-規模,佔有率,展望,機會分析,2023~2030年

Smart Inhalers Market, By Product ((Inhalers (Metered Dosage Inhalers and Dry Powder Inhalers and Nebulizers), By Distribution Channel, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 169 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

市場動態:

呼吸疾病盛行率的上升,全球老年人口的增加,全球COVID-19發生,智慧吸入器的需求/採用的增加,促進全球智慧吸入器市場成長。

本調查的主要特徵

  • 本報告提供以2021年為基準年的預測期間(2022-2030 年)之全球智慧吸入器市場的市場規模和復合年增長率(CAGR %)相關的詳細分析。
  • 並闡明不同部門市場的潛在收入機會,說明該市場具有魅力的投資主張矩陣。
  • 同時並提供市場推動因素和限制、機會、新產品發佈或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
  • 並基於企業亮點,各類型投資組合、主要焦點、財務業績和市場策略等參數,介紹全球智慧吸入器市場的主要參與者之企業簡介。
  • 藉由該報告提供的洞察,將能幫助營銷人員和公司高管能夠就未來的產品發佈、類型升級、市場擴張和營銷策略做出明智的決策。
  • 全球智慧吸入器市場報告配合該行業的各種利益相關者,包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以透過全球智慧吸入器市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查的目的與前提條件

  • 調查的目的
  • 前提條件
  • 簡稱

第2章 市場展望

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
  • 連貫·機遇·地圖(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 影響分析
  • 主要的焦點
  • 法規情勢
  • 產品銷售/核准
  • PEST分析
  • 波特分析
  • 合併·收購情勢

第4章 智慧吸入器的全球市場-冠狀病毒(COVID-19)大流行病的影響

  • 關於COVID-19流行病學
  • 供給面和需求面的分析
  • 經濟影響

第5章 智慧吸入器的全球市場,各類型,2017年~2030年

  • 吸入器
  • 定量噴霧吸入器(MDI)
  • 乾粉吸入器(DPI)
  • 噴霧器

第6章 智慧吸入器的全球市場,各流通管道,2017年~2030年

  • 醫院
  • 藥局

第7章 智慧吸入器的全球市場,各地區,2017年~2030年

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲地區

第8章 競爭情形

  • Adherium Limited
  • AstraZeneca
  • Boehringer Ingelheim
  • Cohero Health
  • GSK
  • Novartis
  • ResMed

第9章 章節

  • 關於調查手法
  • 關於出版社
簡介目錄
Product Code: CMI5738

A smart inhaler is a medical device that integrates connectivity with a mobile app, via Bluetooth, for instance. These devices are built with sensor technology that helps record data about the time and date of use, and the location of the patient at each use.

Market Dynamics:

Rise in prevalence of respiratory disorders, growing geriatric (aging) population around the world, the outbreak of COVID-19 across the globe, and increasing demand/adoption of smart inhalers are major factors expected to drive growth of the global smart inhalers market. For instance, In January 2023, Aseptika won an Innovate UK Smart Award to develop a Smart Inhaler Tracker for patients with lung health conditions. The Smart Award will help the company develop its third-generation smart inhaler tracker, which will have 5G mobile connectivity built-in. This means that patients will no longer have to send their data via a smartphone to their clinical teams, carers, or parent; it will just send information over the airwaves directly to the company's cloud databases.

Key features of the study:

  • This report provides in-depth analysis of the global smart inhalers market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global smart inhalers market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Adherium Limited, AstraZeneca, Boehringer Ingelheim, Cohero Health, GSK, Novartis, and ResMed, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global smart inhalers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smart inhalers market.

Detailed Segmentation:

  • Global Smart Inhalers Market, By Product:
    • Inhalers
    • Metered Dosage Inhalers (MDIs)
    • Dry Powder Inhalers (DPIs)
    • Nebulizers
  • Global Smart Inhalers Market, By Distribution Channel:
    • Hospitals
    • Pharmacies
  • Global Smart Inhalers Market, By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • Adherium Limited
    • AstraZeneca
    • Boehringer Ingelheim
    • Cohero Health
    • GSK
    • Novartis
    • ResMed

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Distribution channel
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in prevalence of respiratory disorders
    • Lack of awareness and high cost of smart inhalers
    • Increasing demand/adoption of smart inhalers
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Smart Inhalers Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Smart Inhalers Market, By Type, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Inhalers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Metered Dosage Inhalers (MDIs)
  • Dry Powder Inhalers (DPIs)
  • Nebulizers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Smart Inhalers Market, By Distribution channel, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Smart Inhalers Market, By Geography, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2017-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2017-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2017-2030,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2017-2030,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2017-2030,(US$ Mn)

8. Competitive Landscape

  • Adherium Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cohero Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GSK
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ResMed
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us